These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 32998687)
1. Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease. Guiedem E; Pefura-Yone EW; Ikomey GM; Nkenfou CN; Mesembe M; Yivala MM; Chendi BH; Jacobs GB; Chegou NN; Okomo MCA BMC Immunol; 2020 Oct; 21(1):52. PubMed ID: 32998687 [TBL] [Abstract][Full Text] [Related]
2. Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey. Xing Z; Sun T; Janssens JP; Chai D; Liu W; Tong Y; Wang Y; Ma Y; Pan M; Cui J; Wang C; Guo Y Thorax; 2023 Mar; 78(3):274-280. PubMed ID: 35361688 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory Cytokines and T-Lymphocyte Subsets in Serum and Sputum in Patients with Bronchial Asthma and Chronic Obstructive Pulmonary Disease. Bai Y; Zhou Q; Fang Q; Song L; Chen K Med Sci Monit; 2019 Mar; 25():2206-2210. PubMed ID: 30908476 [TBL] [Abstract][Full Text] [Related]
4. Increased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary disease. Tang S; Cui H; Yao L; Hao X; Shen Y; Fan L; Sun H; Zhang Z; Huang JA PLoS One; 2013; 8(4):e62385. PubMed ID: 23626814 [TBL] [Abstract][Full Text] [Related]
5. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies. Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study. Costiniuk CT; Nitulescu R; Saneei Z; Wasef N; Salahuddin S; Wasef D; Young J; de Castro C; Routy JP; Lebouché B; Cox J; Smith BM; Ambroise S; Pexos C; Patel M; Szabo J; Haraoui LP; de Pokomandy A; Tsoukas C; Falutz J; LeBlanc R; Giannakis A; Frenette C; Jenabian MA; Bourbeau J; Klein MB HIV Med; 2019 Mar; 20(3):192-201. PubMed ID: 30620136 [TBL] [Abstract][Full Text] [Related]
7. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease. Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory and immunological profiles in patients with COPD: relationship with FEV 1 reversibility. Queiroz CF; Lemos AC; Bastos ML; Neves MC; Camelier AA; Carvalho NB; Carvalho EM J Bras Pneumol; 2016; 42(4):241-247. PubMed ID: 27832230 [TBL] [Abstract][Full Text] [Related]
9. Severe COPD cases from Korea, Poland, and USA have substantial differences in respiratory symptoms and other respiratory illnesses. Kim WJ; Yim JJ; Kim DK; Lee MG; Fuhlbrigge AL; Sliwinski P; Hawrylkiewicz I; Wan ES; Cho MH; Silverman EK Int J Chron Obstruct Pulmon Dis; 2017; 12():3415-3423. PubMed ID: 29238186 [TBL] [Abstract][Full Text] [Related]
10. Impact of Previous Pulmonary Tuberculosis on Chronic Obstructive Pulmonary Disease: Baseline Results from a Prospective Cohort Study. Wang Y; Li Z; Li F Comb Chem High Throughput Screen; 2023; 26(1):93-102. PubMed ID: 35388750 [TBL] [Abstract][Full Text] [Related]
11. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses]. Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory cell profiles and T-lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma. Tsoumakidou M; Tzanakis N; Kyriakou D; Chrysofakis G; Siafakas NM Clin Exp Allergy; 2004 Feb; 34(2):234-40. PubMed ID: 14987303 [TBL] [Abstract][Full Text] [Related]
13. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. Zhang J; Lin XF; Bai CX Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780 [TBL] [Abstract][Full Text] [Related]
15. Increased production of TGF-β1 from sputum cells of COPD: Relationship with airway obstruction. Godinas L; Corhay JL; Henket M; Guiot J; Louis R; Moermans C Cytokine; 2017 Nov; 99():1-8. PubMed ID: 28668545 [TBL] [Abstract][Full Text] [Related]
16. Airflow obstruction and chronic obstructive pulmonary disease are common in pulmonary tuberculosis even without sequelae findings on chest X-ray. Park HJ; Byun MK; Lee J; Kim CY; Shin S; Kim Y; Rhee CK; Jung KS; Yoo KH Infect Dis (Lond); 2023 Aug; 55(8):533-542. PubMed ID: 37243367 [TBL] [Abstract][Full Text] [Related]
17. Sputum Biomarkers in Wood and Tobacco Smoke Etiotypes of Chronic Obstructive Pulmonary Disease. Giraldo-Montoya ÁM; Torres-Duque CA; Giraldo-Cadavid LF; Laucho-Contreras ME; González-Flórez A; Santos AM; Tuta-Quintero EA; Celli BR; González-García M Int J Chron Obstruct Pulmon Dis; 2024; 19():1-10. PubMed ID: 38179428 [TBL] [Abstract][Full Text] [Related]
18. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322 [TBL] [Abstract][Full Text] [Related]